Once the cancer cells escape the inhibitory effect of TGF-β, they begin to overexpress TGF-β to create a more aggressive tumor phenotype through the promotion of EMT, increased tumor invasion, metastasis, and angiogenesis, as well as immune evasion [28]. The gene discussed is TGFB1; the disease is neoplasm.